Personalis
James Azzaro joined Personalis in April 2022 as Vice President of Diagnostic Sales with over 20 years of experience as a commercial leader in the oncology molecular diagnostics industry. Throughout his career, James has led sales teams for public and private companies through multiple product launches and periods of significant volume and revenue growth. Prior to joining Personalis, James was Chief Commercial Officer for Predicine, a private oncology focused molecular laboratory from 2021-2022. James held the position of National Sales Director at Guardant Health from 2017-2021, a publicly traded oncology molecular laboratory. James started his career with Myriad genetics, a publicly traded genetics laboratory where he held multiple commercial positions from 2002- 2017.
This person is not in the org chart
This person is not in any offices
Personalis
4 followers
Personalis is a leader in population sequencing and cancer genomics, with a focus on data, scale, efficiency and quality. Personalis operates one of the largest sequencing operations globally and is currently the sole sequencing provider to the VA Million Veteran Program (MVP). In oncology, Personalis is transforming the development of next-generation therapies by providing more comprehensive molecular data about each patient’s cancer and immune response. The Personalis® ImmunoID NeXT Platform® is designed to adapt to the complex and evolving understanding of cancer, providing its biopharmaceutical customers with information on all of the approximately 20,000 human genes, together with the immune system, from a single tissue sample. The Personalis Clinical Laboratory is GxP-aligned as well as CLIA’88-certified and CAP-accredited.